We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Chesnara Plc | LSE:CSN | London | Ordinary Share | GB00B00FPT80 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.50 | 0.20% | 249.50 | 249.00 | 250.50 | 251.50 | 247.00 | 247.00 | 299,695 | 14:52:48 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Life Insurance | 488.8M | 18.7M | 0.1243 | 20.07 | 375.32M |
Date | Subject | Author | Discuss |
---|---|---|---|
11/4/2024 08:09 | 'The recommended final dividend of 15.61p per share is expected to be paid on 28 May 2024. The ordinary shares will be quoted ex-dividend on the London Stock Exchange as of 11 April 2024.' | mister md | |
09/4/2024 10:13 | Also its had quite a run recently :- free stock charts from uk.advfn.com | skinny | |
09/4/2024 10:10 | People selling out before xd drop. | orchestralis | |
08/4/2024 13:51 | CSN always a little slow to the party. | cassini | |
05/4/2024 09:04 | Chart looking impressive now. | mister md | |
03/4/2024 19:35 | Back up to my average price now ;0) | cassini | |
03/4/2024 19:12 | Not an exciting share but makes you wealthier. Slowly but surely. | dosser50 | |
03/4/2024 17:15 | It begins to look (fingers cossed) as though those of us here who were buyers under 260 may have got it about right. I hope i am not temping fate. | 1knocker | |
03/4/2024 15:06 | Director buy. | mister md | |
30/3/2024 07:41 | Thank you for that unastubbs. As I have said in the past, "Earn cash" is an anagram of Chesnara. | mirandaj | |
30/3/2024 07:09 | Tempus The Times | unastubbs | |
28/3/2024 16:14 | Disappointing that new business was down at Scildon (-11%) and Movestic (-18%) | makinbuks | |
28/3/2024 16:03 | Volume seems very high today by the looks. | luderitz | |
28/3/2024 16:01 | Investor Relations shows today's presentation: Scroll down | mirandaj | |
28/3/2024 10:53 | You have trumped me then, P, as mine was at 179. My last sale was at 307, followed by repurchase and top up at 260, and a tad under 253 though! It would be great if we can re-establish the old 275 /305 trading range. For years it was just a case of setting the limit orders and letting them get on with the job. Over the years, trading that range has been at least as lucrative as the dividend . Together, they have provided a very impressive return on a 'boring' stock. | 1knocker | |
28/3/2024 10:11 | Agreed mr B My first purchase was at £1.70 | phillis | |
28/3/2024 09:19 | Entirely agree that we don't expect (and don't hold CSN for) fireworks. Those results and dividend look very satisfactory to me. | 1knocker | |
28/3/2024 09:07 | Yes when rates are cut will look even better. | patient fox | |
28/3/2024 08:47 | Uninspiring, Wizard. Possibly, but isn't that what CSN is supposed to be? 3% rise in dividend may be less than inflation but 9% pay out certainly isn't! | theapiarist | |
28/3/2024 08:22 | Uninspiring. The fact that the share price rose shows how negative the market view was. Div effectively falls in real terms. | wizard2020 | |
28/3/2024 08:19 | Shame the excess cash is not being used for a buyback. Missed opportunity. spud | jonnybig | |
28/3/2024 07:59 | Very solid set of results I would have thought | panshanger1 | |
28/3/2024 07:44 | It’s not about anyone calling it right or wrong it’s about a continuous increase in share price generally. | luderitz | |
28/3/2024 07:28 | Tag57 called it right in 2359 | mirandaj | |
28/3/2024 07:01 | . CONTINUED STRONG CASH GENERATION WITH POSITIVE OUTLOOK FOR FURTHER M&A Chesnara reports its 2023 full year results. Key highlights are: · Completion of the acquisition of Conservatrix's insurance portfolio in the Netherlands · Acquisition of an individual protection portfolio from Canada Life UK · New UK strategic partnership with SS&C Technologies for policy administration · Strong group commercial cash generation of £53.0m (FY 2022: £46.6m) · Robust solvency of 205% (FY 2022: 197%), materially above our 140 - 160% normal operating range · Economic value ("EcV") of £524.7m, 348p per share (FY 2022: £511.7m, 340p per share) · Commercial value of new business of £10.1m (FY 2022: £9.5m) · Proposed 3% increase to the full year dividend (total 2023 dividend of 23.97p per share) · IFRS pre-tax profit of £1.8m (FY 2022: £62.1m loss) | skinny |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions